Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 04 Jul 2026 · HPRA open data

Instituto Biochimico Italiano G. Lorenzini S.p.A. — Licensed Medicines

4 medicines held by Instituto Biochimico Italiano G. Lorenzini S.p.A. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 4 products held by Instituto Biochimico Italiano G. Lorenzini S.p.A.

Medicine	Active substance	Licence holder	Status
Co-amoxiclav 1000 mg/200 mg powder for solution for injection/infusion PA2220/002/002	Amoxicillin, Clavulanic acid	Instituto Biochimico Italiano G. Lorenzini S.p.A.	Marketed
Co-amoxiclav 2000 mg/200 mg powder for solution for infusion PA2220/002/003	Amoxicillin, Clavulanic acid	Instituto Biochimico Italiano G. Lorenzini S.p.A.	Not marketed
Co-amoxiclav 500 mg/100 mg powder for solution for injection/infusion PA2220/002/001	Amoxicillin, Clavulanic acid	Instituto Biochimico Italiano G. Lorenzini S.p.A.	Marketed
Voriconazole Ibisqus 200 mg powder for solution for infusion PA2220/001/001	Voriconazole	Instituto Biochimico Italiano G. Lorenzini S.p.A.	Not marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.